153 related articles for article (PubMed ID: 11839736)
1. Entry into cells and selective degradation of tRNAs by a cytotoxic member of the RNase A family.
Saxena SK; Sirdeshmukh R; Ardelt W; Mikulski SM; Shogen K; Youle RJ
J Biol Chem; 2002 Apr; 277(17):15142-6. PubMed ID: 11839736
[TBL] [Abstract][Full Text] [Related]
2. Onconase action on tRNA(Lys3), the primer for HIV-1 reverse transcription.
Suhasini AN; Sirdeshmukh R
Biochem Biophys Res Commun; 2007 Nov; 363(2):304-9. PubMed ID: 17888404
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of apoptosis induced by the cytotoxic ribonuclease onconase: evidence for cytotoxic mechanisms different from inhibition of protein synthesis.
Iordanov MS; Ryabinina OP; Wong J; Dinh TH; Newton DL; Rybak SM; Magun BE
Cancer Res; 2000 Apr; 60(7):1983-94. PubMed ID: 10766189
[TBL] [Abstract][Full Text] [Related]
4. Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.
Newton DL; Boque L; Wlodawer A; Huang CY; Rybak SM
Biochemistry; 1998 Apr; 37(15):5173-83. PubMed ID: 9548748
[TBL] [Abstract][Full Text] [Related]
5. Angiogenin is a cytotoxic, tRNA-specific ribonuclease in the RNase A superfamily.
Saxena SK; Rybak SM; Davey RT; Youle RJ; Ackerman EJ
J Biol Chem; 1992 Oct; 267(30):21982-6. PubMed ID: 1400510
[TBL] [Abstract][Full Text] [Related]
6. Transfer RNA cleavages by onconase reveal unusual cleavage sites.
Suhasini AN; Sirdeshmukh R
J Biol Chem; 2006 May; 281(18):12201-9. PubMed ID: 16497678
[TBL] [Abstract][Full Text] [Related]
7. A cytotoxic ribonuclease. Study of the mechanism of onconase cytotoxicity.
Wu Y; Mikulski SM; Ardelt W; Rybak SM; Youle RJ
J Biol Chem; 1993 May; 268(14):10686-93. PubMed ID: 8486718
[TBL] [Abstract][Full Text] [Related]
8. Transfer RNA is required for conjugation of ubiquitin to selective substrates of the ubiquitin- and ATP-dependent proteolytic system.
Ferber S; Ciechanover A
J Biol Chem; 1986 Mar; 261(7):3128-34. PubMed ID: 3005281
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of HIV-1 production and selective degradation of viral RNA by an amphibian ribonuclease.
Saxena SK; Gravell M; Wu YN; Mikulski SM; Shogen K; Ardelt W; Youle RJ
J Biol Chem; 1996 Aug; 271(34):20783-8. PubMed ID: 8702832
[TBL] [Abstract][Full Text] [Related]
10. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes.
Ardelt W; Shogen K; Darzynkiewicz Z
Curr Pharm Biotechnol; 2008 Jun; 9(3):215-25. PubMed ID: 18673287
[TBL] [Abstract][Full Text] [Related]
11. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
[TBL] [Abstract][Full Text] [Related]
12. [Effective expression of ribonuclease-onconase in Escherichia coli and assaying its cytotoxic potential].
Xu GF; Wang QC; Gong XG; Fei J
Shi Yan Sheng Wu Xue Bao; 2004 Jun; 37(3):227-31. PubMed ID: 15323425
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the mechanism of cellular and cell free protein synthesis inhibition by an anti-tumor ribonuclease.
Lin JJ; Newton DL; Mikulski SM; Kung HF; Youle RJ; Rybak SM
Biochem Biophys Res Commun; 1994 Oct; 204(1):156-62. PubMed ID: 7945354
[TBL] [Abstract][Full Text] [Related]
14. Ribonucleases as potential modalities in anticancer therapy.
Ardelt W; Ardelt B; Darzynkiewicz Z
Eur J Pharmacol; 2009 Dec; 625(1-3):181-9. PubMed ID: 19825371
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic ribonucleases and RNA interference (RNAi).
Ardelt B; Ardelt W; Darzynkiewicz Z
Cell Cycle; 2003; 2(1):22-4. PubMed ID: 12695680
[TBL] [Abstract][Full Text] [Related]
16. Effect of Onconase on double-stranded RNA in vitro.
Saxena A; Saxena SK; Shogen K
Anticancer Res; 2009 Apr; 29(4):1067-71. PubMed ID: 19414347
[TBL] [Abstract][Full Text] [Related]
17. Expression and characterization of a cytotoxic human-frog chimeric ribonuclease: potential for cancer therapy.
Newton DL; Xue Y; Boqué L; Wlodawer A; Kung HF; Rybak SM
Protein Eng; 1997 Apr; 10(4):463-70. PubMed ID: 9194172
[TBL] [Abstract][Full Text] [Related]
18. Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.
Menegazzi M; Gotte G
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742999
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.
Tsai SY; Ardelt B; Hsieh TC; Darzynkiewicz Z; Shogen K; Wu JM
Int J Oncol; 2004 Dec; 25(6):1745-52. PubMed ID: 15547713
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of vincristine cytotoxicity in drug-resistant cells by simultaneous treatment with onconase, an antitumor ribonuclease.
Rybak SM; Pearson JW; Fogler WE; Volker K; Spence SE; Newton DL; Mikulski SM; Ardelt W; Riggs CW; Kung HF; Longo DL
J Natl Cancer Inst; 1996 Jun; 88(11):747-53. PubMed ID: 8637029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
